Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Hologic, Inc shares valued at $300,760 were purchased by Madaus Martin D on May 07 ’25. At $55.24 per share, Madaus Martin D acquired 5,445 shares. The insider’s holdings grew to 5,445 shares worth approximately $0.34 million following the completion of this transaction.
Also, Mitchell Essex D sold 24,856 shares, netting a total of over 1,897,482 in proceeds. Following the sale of shares at $76.34 each, the insider now holds 27,957 shares.
Before that, Mitchell Essex D had added 24,856 shares to its account. In a trade valued at $1,897,484, the Officer bought Hologic, Inc shares for $76.34 each.
As published in a research note from Needham on May 27, 2025, Hologic, Inc [HOLX] has been retained to a Hold. Analysts at Argus downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in early March. As of February 06, 2025, Leerink Partners has decreased its “an Outperform” rating to a “Market perform” for HOLX. Earlier on February 03, 2025, Needham downgraded its rating. Their new recommendation was “a Hold” for HOLX stock which previously was a “a Buy”.
Analyzing HOLX Stock Performance
During the last five days, there has been a surge of approximately 14.78%. Over the course of the year, Hologic, Inc shares have dropped approximately -12.72%. Shares of the company reached a 52-week high of $74.50 on 01/06/25 and a 52-week low of $51.90 on 05/06/25.
Support And Resistance Levels for Hologic, Inc (HOLX)
According to the 24-hour chart, there is a support level at 62.62, which, if violated, would cause prices to drop to 62.33. In the upper region, resistance lies at 63.47. The next price resistance is at 64.03. RSI (Relative Strength Index) is 64.12 on the 14-day chart, showing neutral technical sentiment.
